Notice of Registration - 2011
[Federal Register Volume 76, Number 160 (Thursday, August 18, 2011)]
[Notices]
[Pages 51402-51403]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-21073]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated April 11, 2011, and published in the Federal
Register on April 19, 2011, 76 FR 21916, Norac Inc., 405 S. Motor
Avenue, P.O. Box 577, Azusa, California 91702-3232, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of the following basic classes of controlled
substances:
| Drug |
Schedule |
| Gamma Hydroxybutyric Acid (2010) |
I |
| Tetrahydrocannabinols (7370) | I |
| Methamphetamine (1105) |
II |
| Pentobarbital (2270) |
II |
| Nabilone (7379) | II |
With regard to Gamma Hydroxybutyric Acid (2010),
Tetrahydrocannabinols (7370), and Methamphetamine (1105) only, the
company manufactures these controlled substances in bulk solely for
domestic distribution within the United States to customers engaged in
dosage-form manufacturing.
With regard to Nabilone (7379) only, the company presently
manufactures a small amount of this controlled substance in bulk solely
to conduct manufacturing process development within the company. It is
the company's intention that, when the manufacturing process is refined
to the point that its Nabilone bulk product is available for commercial
use, the company will export the controlled substance in bulk solely to
customers engaged in dosage-form manufacturing outside the United
States. The company is aware of the requirement to obtain a DEA
registration as an exporter to conduct this activity.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Norac, Inc. to manufacture the listed basic classes of controlled
substances is consistent with the public interest at this time. DEA has
investigated Norac, Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above
named company is granted registration as a bulk manufacturer of the
basic classes of controlled substances listed.
Dated: August 9, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-21073 Filed 8-17-11; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |